Public procurement notice: Contract Notice
Published: 2019-03-15
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (“NSS”)
Country: UK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33600000: Pharmaceutical products
Estimated value: 45000000 GBP
Submission deadline: 2019-04-15
Award criteria: The most economic tender

Technical requirements: This procurement is for the supply of medicines used in the treatment of Hepatitis C to NHS Scotland.
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
This Framework Agreement is for the supply of generic medicines under a capped spend model used in the treatment of Hepatitis C to NHSScotland.
This lot will be awarded as an unranked multi supplier Framework Agreement to a maximum of three (3) suppliers.
The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twelve (12) months by giving a minimum of three (3) months written notice of such extension(s).
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
This Framework Agreement is for the supply of medicines used in the treatment of Hepatitis C to NHSScotland.
The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twelve (12) months by giving a minimum of three (3) months written notice of such extension(s).
Economic operators may be excluded from this competition if they are in breach of any situation referred to in Regulation 58 of the Public Contracts (Scotland) Regulations 2015.
(a) potential framework participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered medicines at the date of submission of the tender;
(b) potential framework participants and any subcontractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.
(a) confirmation of existence of a current and valid UK Marketing Authorisation, or EMA Marketing Authorisation that has been approved by the MHRA, at the date of submission of the tender should be included in the qualification envelope of the ITT under the technical and professional ability: quality control for all tendered medicines;
(b) confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the quality assurance schemes.
The estimated value range referred to in Sections II.I.5) and all lots covers the twenty two (22) months initial duration and the maximum twelve (12) month extension period.
The Contracting Authority does not intend to include a subcontract clause as part of community benefits (as per Section 25 of the Procurement Reform (Scotland) Act 2014) in this contract for the following reason:

Eligibility requirements: Economic operators may be excluded from this competition if they are in breach of any situation referred to in Regulation 58 of the Public Contracts (Scotland) Regulations 2015.

Award value: 45000000